I am astonished at the subdued response to the news of BARDA funding for phase 3 trials for LANI worldwide.
My concerns crystallised this morning by the takeover of CST for A$341m.
Surely BTA is worth at least as much as CST and arguably more. But we are capitalised a "mere" A$259m.
Without going into all the detail - it's all here on HC, we are in grave danger of premature death through takeover. There are many Life Sciences companies for whom we would be a perfect fit and company maker.
I hope management feel the same.
- Forums
- ASX - By Stock
- BTA
- subdued response
subdued response
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)